Participants may not have received any prior treatment with therapies targeting PDL1, PD1 or CTLA4
Prior PD-1 or CTLA-4 targeted therapies are excluded
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Prior PD-1 or CTLA-4 targeted therapies are excluded.
Receipt of anti-CTLA-4 targeted therapies or other checkpoint or co-stimulatory therapy within 3 months prior to start of study treatment.